Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.
2 reports, 1 independent
Updated Aug 28
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- MarketBeat reports consensus rating and price target for Eikon Therapeutics, Inc., alongside rating updates from Cantor Fitzgerald and Manufacturers Life Insurance Company.Sub-event
- Cantor Fitzgerald increased its price objective on Hyperion DeFi, while MarketBeat reported the average rating and target price.Sub-event
Multiple analysts issued rating upgrades and price targets for various stocks on Aug 10.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
MarketBeat
American personal finance blog
Related events
- Cantor Fitzgerald and Citigroup issued rating updates, while MarketBeat reported research notes on Quince Therapeutics.
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald reiterated an overweight rating on CleanSpark shares.
- Cantor Fitzgerald reiterated an Overweight rating on Amazon stock.